Diagnosis is just the beginning of the battle

The UK lags behind other countries in getting the right treatments to rare disease patients, but promising developments are underway in a bid to help improve access

How rare diseases can impact mental health

Mental health is fast becoming recognised as the missing piece of the puzzle in rare disease support

Why buyers’ clubs are the last option for desperate families

How an ongoing pricing battle between the NHS and an American biopharmaceutical giant led to a buyers’ club for cystic fibrosis drugs in the UK

Why are orphan drugs so expensive?

Current methods to determine the right value for orphan drugs remain controversial, yet the fast-tracking of new therapies marks a big step forward for the industry

Healthcare technology will change lives, eventually

There is some way to go before game-changing technologies are deployed to revolutionise patient care and the working practices of healthcare professionals, but there are encouraging signs of progress

How 5G can revolutionise healthcare

For all the transformative and life-saving benefits that 5G has to offer, a number of obstacles stand in the way of the NHS capitalising on the technology

We’re living much longer, but are we healthier?

Increases in life expectancy will put unprecedented pressure on our healthcare systems. Exploring the science of ageing and our understanding of co-morbidities will be crucial in tackling this ‘longevity trap’

Better patient compliance could save millions

Digital medicine could provide the answer to the costly questions of patient compliance and failure to follow medical advice correctly